检索结果 - Ben Ho

Refine Results
  1. 1
    Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy

    Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy 由 Justin Cidado, Ben Ho Park

    出版 2012
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    PIK3CA and KRAS mutations predict for response to everolimus therapy: now that’s RAD001

    PIK3CA and KRAS mutations predict for response to everolimus therapy: now that’s RAD001 由 Mohseni, Morassa, Park, Ben Ho

    出版 2010
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    BEAMing sheds light on drug resistance

    BEAMing sheds light on drug resistance 由 Lauring, Josh, Park, Ben Ho

    出版 2011
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy

    Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy 由 Cidado, Justin, Park, Ben Ho

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    ESR1 mutations: Pièce de résistance

    ESR1 mutations: Pièce de résistance 由 Button, Berry, Park, Ben Ho

    出版 2016
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    p21 and p27: roles in carcinogenesis and drug resistance

    p21 and p27: roles in carcinogenesis and drug resistance 由 Abde M. Abukhdeir, Ben Ho Park

    出版 2008
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    The BOLERO-2 Trial: The Addition of Everolimus to Exemestane in the Treatment of Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer

    The BOLERO-2 Trial: The Addition of Everolimus to Exemestane in the Treatment of Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer 由 Julia A. Beaver, Ben Ho Park

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Circulating tumor DNA: current challenges for clinical utility

    Circulating tumor DNA: current challenges for clinical utility 由 Donna K. Dang, Ben Ho Park

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    p21 and p27: roles in carcinogenesis and drug resistance

    p21 and p27: roles in carcinogenesis and drug resistance 由 Abukhdeir, Abde M., Park, Ben Ho

    出版 2008
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  10. 10
    Plasma tumor DNA: on your markers, get set, go!

    Plasma tumor DNA: on your markers, get set, go! 由 Wong, Hong Yuen, Park, Ben Ho

    出版 2014
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  11. 11
    Genetic disruption of <i>PPAR</i> δ decreases the tumorigenicity of human colon cancer cells

    Genetic disruption of <i>PPAR</i> δ decreases the tumorigenicity of human colon cancer cells 由 Ben Ho Park, Bert Vogelstein, Kenneth W. Kinzler

    出版 2001
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer

    The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer 由 Josh Lauring, Ben Ho Park, Antonio C. Wolff

    出版 2013
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  13. 13
    CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors

    CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors 由 Sarah C. Reed, Sarah Croessmann, Ben Ho Park

    出版 2022
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  14. 14
    Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells

    Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells 由 Park, Ben Ho, Vogelstein, Bert, Kinzler, Kenneth W.

    出版 2001
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  15. 15
    The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer

    The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer 由 Lauring, Josh, Park, Ben Ho, Wolff, Antonio C.

    出版 2013
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  16. 16
    Needles in a haystack: finding recurrent genomic changes in breast cancer

    Needles in a haystack: finding recurrent genomic changes in breast cancer 由 Cidado, Justin, Beaver, Julia A, Park, Ben Ho

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  17. 17
    Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity

    Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity 由 Eric S. Christenson, Theodore James, Vineet Agrawal, Ben Ho Park

    出版 2014
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  18. 18
    The PIK3CA Gene as a Mutated Target for Cancer Therapy

    The PIK3CA Gene as a Mutated Target for Cancer Therapy 由 Gustin, John P., Cosgrove, David P., Park, Ben Ho

    出版 2008
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  19. 19
    mTOR Signaling Feedback Modulates Mammary Epithelial Differentiation and Restrains Invasion Downstream of PTEN Loss

    mTOR Signaling Feedback Modulates Mammary Epithelial Differentiation and Restrains Invasion Downstream of PTEN Loss 由 Ghosh, Susmita, Varela, Lidenys, Sood, Akshay, Park, Ben Ho, Lotan, Tamara L.

    出版 2013
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  20. 20
    AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer

    AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer 由 Jhaveri, Teraneh Z., Woo, Juhyung, Shang, Xiaobin, Park, Ben Ho, Gabrielson, Edward

    出版 2015
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: